Clinical Trials Browser

Completed × Observational × Alpelisib × Clear all

NCT06083038 2026-05-06

Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib

Breast Neoplasms, Hyperglycemia

NCT05022342 2026-02-23

SPEAR

Breast Neoplasms

NCT04285723 2023-02-09

EPIK-P1

57 enrolled 23 charts 1 FDA

Hereditary Sensory and Autonomic Neuropathies